• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    B
    Boston Bio Systems Ltd.
    05 Feb 2025
    7.82
    -4.98%
    Boston Scientific sees higher-than-expected 2025 profit on strong demand
    Boston Scientific sees higher-than-expected 2025 profit on strong demand
    livemint
    BOSTON-RESULTS/:Boston Scientific sees higher-than-expected 2025 profit on strong demand
    Copy LinkShare onShare on Share on Share on
    Boston Bio Systems Ltd.'s price crossed below 30Day SMA today
    logo
    Dr. Lal Pathlabs Ltd.
    05 Feb 2025
    Insider Trades
    3372.60
    2.65%
    Dividend stocks 2025: Shree Cement, Coromandel International, Dr Lal PathLabs to trade ex-date today
    Dividend stocks 2025: Shree Cement, Coromandel International, Dr Lal PathLabs to trade ex-date today
    livemint
    Dividend stocks 2025: Shree Cement, Coromandel International, Dr Lal PathLabs share prices will remain in focus as will traded trade ex-date today. Check for Dividend details and payout dates
    Copy LinkShare onShare on Share on Share on
    Dr. Lal Pathlabs Ltd.'s price crossed above 30Day SMA today
    logo
    Metropolis Healthcare Ltd.
    03 Feb 2025
    2092.80
    2.23%
    Metropolis Healthcare, Roche team up to launch HPV DNA testing in India
    Business Standard
    "The HPV test will be rolled out on February 4 to coincide with World Cancer Day," an official with Metropolis said
    Copy LinkShare onShare on Share on Share on
    Metropolis Healthcare Ltd. is trading above its 200 day SMA of 1845.7
    logo
    Dr. Lal Pathlabs Ltd.
    30 Jan 2025
    Insider Trades
    3372.60
    2.65%
    Dr Lal Q3FY25 results: PAT jumps 19% to Rs 98 crore as volumes grow
    Business Standard
    As for Suburban Diagnostics, an arm of Dr Lal Pathlabs, revenue growth was 9.2 per cent in Q3
    Copy LinkShare onShare on Share on Share on
    Dr. Lal Pathlabs Ltd. has gained 33.19% in the last 6 Months
    Dr Lal Path Labs Q3FY25 results: Net profit jumps 19% to Rs 96.7 crore
    Business Standard | 30 Jan 2025
    logo
    Thyrocare Technologies Ltd.
    27 Jan 2025
    1196.20
    0.13%
    'EMI gets high-end cars and artificial high...': Thyrocare founder's choice for a ride sparks debate
    'EMI gets high-end cars and artificial high...': Thyrocare founder's choice for a ride sparks debate
    Business Today
    Dr. Velumani's preference for economical travel is not new. In a prior post, he shared his decision to take a local train in Mumbai instead of a car, cutting his commute from 70 minutes to just 18. However costly the car is, in Mumbai for time management, just board a Local, he explained.
    Copy LinkShare onShare on Share on Share on
    Thyrocare Technologi.. has an average target of 1000.00 from 1 broker.
    logo
    Thyrocare Technologies Ltd.
    24 Jan 2025
    1196.20
    0.13%
    Thyrocare Technologies Q3 Results 2025 on 24 Jan, 2025: profit rise by 24.5% YOY, profit at 19.11 crore and revenue at 165.92 crore
    Thyrocare Technologies Q3 Results 2025 on 24 Jan, 2025: profit rise by 24.5% YOY, profit at 19.11 crore and revenue at 165.92 crore
    livemint
    Thyrocare Technologies Q3 Results 2025 on 24 Jan, 2025: Revenue increased by 23.14% YoY & profit increased by 24.5% YoY, profit at 19.11 crore and revenue at 165.92 crore
    Copy LinkShare onShare on Share on Share on
    Thyrocare Technologies Ltd. is trading above its 200 day SMA of 969.1
    Tech Query: What is the outlook for Thyrocare Technologies and Karnataka Bank?
    Business Line | 23 Jan 2025
    logo
    Dr. Lal Pathlabs Ltd.
    23 Jan 2025
    Insider Trades
    3372.60
    2.65%
    Dr Lal PathLabs sets board meeting date to declare Q3 results 2025, interim dividend
    Dr Lal PathLabs sets board meeting date to declare Q3 results 2025, interim dividend
    livemint
    Dr Lal PathLabs will announce its Q3 results for FY25 on January 30, 2025. The Board of Directors will also discuss a third interim dividend for the financial year.
    Copy LinkShare onShare on Share on Share on
    Dr. Lal Pathlabs Ltd. has gained 33.19% in the last 6 Months
    logo
    Dr. Lal Pathlabs Ltd.
    12 Jan 2025
    Insider Trades
    3372.60
    2.65%
    Steady heartbeat of growth in diagnostics stock keeps sector pulsing
    Business Standard
    Realisation growth for Dr Lal PathLabs and Vijaya Diagnostic Centre is projected to remain flat compared to the previous year
    Copy LinkShare onShare on Share on Share on
    Dr. Lal Pathlabs Ltd. is trading above all available SMAs
    logo
    Suraksha Diagnostic Ltd.
    07 Jan 2025
    317.40
    -0.49%
    HMPV In India: What Are The Tests To Detect It, And How Much Do They Cost
    HMPV In India: What Are The Tests To Detect It, And How Much Do They Cost
    NDTV Profit
    Dr Abhirup Sarkar, laboratory director at Suraksha Diagnostics, told NDTV Profit that the virus is typically detected using the PCR method, the same technique employed to identify the coronavirus.
    Copy LinkShare onShare on Share on Share on
    Suraksha Diagnostic .. has an average target of 395.00 from 3 brokers.
    logo
    Dr. Lal Pathlabs Ltd.
    06 Jan 2025
    Insider Trades
    3372.60
    2.65%
    HMPV Outbreak: Diagnostics Stocks Buzz As India Reports Two Cases, Vijaya Diagnostics, Dr. Lal Path Labs Up
    HMPV Outbreak: Diagnostics Stocks Buzz As India Reports Two Cases, Vijaya Diagnostics, Dr. Lal Path Labs Up
    NDTV Profit
    Vijaya Diagnostics and Dr. Lal Path Labs shares gained as much as 2.9% each, while Metropolis Healthcare Ltd. and Thyrocare Technologies Ltd. jumped 1.8%.
    Copy LinkShare onShare on Share on Share on
    Dr. Lal Pathlabs Ltd. has an average target of 3111.40 from 5 brokers.
    more
    loading
    Trendlyne Logo Trendlyne
    Stay ahead of the market
    Markets Today
    • Nifty 50 today
    • Sensex today
    • Latest Quarterly results
    • FII & DII data today
    Dashboard
    • Industry & Sector analysis
    • ETFs
    • Mutual Funds
    • Bullish & Bearish spread
    • Global Indices
    Tools
    • Compare stocks
    • Widgets
    • Data Downloader
    • Excel Connect
    IPOs
    • Dashboard (Mainboard & SME)
    • Upcoming IPOs
    • Recently Listed IPOs
    • Most Successful IPOs
    Upcoming IPOs
    • Vms Tmt
    • Sampat Aluminium
    • JD Cables
    Quick Links
    • Contact us
    • Blogs
    • FAQs
    Company
    • Privacy
    • Terms of Use
    • Disclaimer
    Trendlyne Products
    • Starfolio
    • SmartOptions
    • Trendlyne US Global
    Get Mobile App
    • Android
    • iOS

    Copyright © 2025 Giskard Datatech Pvt Ltd